Global identification of genes and pathways regulated by Akt during activation of T helper cells

F1000Research

Volumn 2, Issue , 2013, Pages

  Kane, Lawrence P ^a   Cheng, Jing ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AKT1 PROTEIN; CCL1 CHEMOKINE; CD28 ANTIGEN; CELL PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MYC PROTEIN; PROTEIN KINASE B; PROTEIN KINASE B BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOINFORMATICS; CCL1 GENE; CCL4 GENE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; EGR1 GENE; ENZYME ACTIVATION; ENZYME INHIBITION; GENE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE INDUCTION; GENE REGULATORY NETWORK; GENE TARGETING; GENETIC VARIABILITY; HELPER CELL; IER3 GENE; IL13 GENE; INTRACELLULAR SIGNALING; MICROARRAY ANALYSIS; NONHUMAN; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; T LYMPHOCYTE ACTIVATION; TH2 CELL;

EID: 84908026014     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.2-109.v2     Document Type: Article

References (57)

1. Li L Ittmann MM Ayala G: The emerging role of the PI3-K-Akt pathway in prostate cancer progression. Prostate Cancer Prostatic Dis. 2005;8(2):108-18. 15724144 10.1038/sj.pcan.4500776
2. Na SY Patra A Scheuring Y: Constitutively active protein kinase B enhances Lck and Erk activities and influences thymocyte selection and activation. J Immunol. 2003;171(3):1285-96. 12874217
3. Cheng J Phong B Wilson DC: Akt Fine-tunes NF-ΚB-dependent gene expression during T cell activation. J Biol Chem. 2011;286(41):36076-85. 21862580 10.1074/jbc.M111.259549 3195567
4. Jones RG Elford AR Parsons MJ: CD28-dependent Activation of Protein Kinase B/Akt Blocks Fas-mediated Apoptosis by Preventing Death-inducing Signaling Complex Assembly. J Exp Med. 2002;196(3):335-48. 12163562 10.1084/jem.20020307 2193932
5. Kane LP Andres PG Howland KC: Akt provides the CD28 costimulatory signal for upregulation of IL-2 and IFN-gamma but not Th2 cytokines. Nat Immunol. 2001;2(1):37-44. 11135576 10.1038/83144
6. Kane LP Shapiro VS Stokoe D: Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol. 1999;9(11):601-604. 10359702 10.1016/S0960-9822(99)80265-6
7. Patra AK Na SY Bommhardt U: Active protein kinase B regulates TCR responsiveness by modulating cytoplasmic-nuclear localization of NFAT and NF-kappa B proteins. J Immunol. 2004;172(8):4812-20. 15067058
8. Pande S Browne G Padmanabhan S: Oncogenic cooperation between PI3K/Akt signaling and transcription factor Runx2 promotes the invasive properties of metastatic breast cancer cells. J Cell Physiol. 2013;228(8):1784-92. 23389849 10.1002/jcp.24339 3685436
9. Ouyang W Liao W Luo CT: Novel Foxo1-dependent transcriptional programs control T(reg) cell function. Nature. 2012;491(7425):554-9. 23135404 10.1038/nature11581 3771531
10. Macintyre AN Finlay D Preston G: Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism. Immunity. 2011;34(2):224-36. 21295499 10.1016/j.immuni.2011.01.012 3052433
11. Hand TW Cui W Jung YW: Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival. Proc Natl Acad Sci U S A. 2010;107(38):16601-6. 20823247 10.1073/pnas.1003457107 2944719
12. Saibil SD Jones RG Deenick EK: CD4+ and CD8+ T cell survival is regulated differentially by protein kinase Ctheta, c-Rel, and protein kinase B. J Immunol. 2007;178(5):2932-9. 17312138
13. Barnett SF Defeo-Jones D Fu S: Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors. Biochem J. 2005;385(Pt 2):399-408. 15456405 10.1042/BJ20041140 1134710
14. Barnett SF Bilodeau MT Lindsley CW: The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation. Curr Top Med Chem. 2005;5(2):109-25. 15853641 10.2174/1568026053507714
15. DeFeo-Jones D Barnett SF Fu S: Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members. Mol Cancer Ther. 2005;4(2):271-9. 15713898
16. Lindsley CW Zhao Z Leister WH: Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors. Bioorg Med Chem Lett. 2005;15(3):761-4. 15664853 10.1016/j.bmcl.2004.11.011
17. Kane LP Mollenauer MN Weiss A: A proline-rich motif in the C terminus of Akt contributes to its localization in the immunological synapse. J Immunol. 2004;172(9):5441-9. 15100285
18. Narayan P Holt B Tosti R: CARMA1 is required for Akt-mediated NF-kappaB activation in T cells. Mol Cell Biol. 2006;26(6):2327-36. 16508008 10.1128/MCB.26.6.2327-2336.2006 1430296
19. Kaye J Porcelli S Tite J: Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells. J Exp Med. 1983;158(3):836-56. 6193236 10.1084/jem.158.3.836 2187090
20. Jordan R Patel S Hu H: Efficiency analysis of competing tests for finding differentially expressed genes in lung adenocarcinoma. Cancer Inform. 2008;6:389-421. 19259419 2623303
21. Patel S Lyons-Weiler J: caGEDA: a web application for the integrated analysis of global gene expression patterns in cancer. Appl Bioinformatics. 2004;3(1):49-62. 16323966 10.2165/00822942-200403010-00007
22. Draghici S Khatri P Tarca AL: A systems biology approach for pathway level analysis. Genome Res. 2007;17(10):1537-45. 17785539 10.1101/gr.6202607 1987343
23. Essaghir A Toffalini F Knoops L: Transcription factor regulation can be accurately predicted from the presence of target gene signatures in microarray gene expression data. Nucleic Acids Res. 2010;38(11):e120. 20215436 10.1093/nar/gkq149 2887972
24. Calleja V Laguerre M Parker PJ: Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition. PLoS Biol. 2009;7(1):e17. 19166270 10.1371/journal.pbio.1000017 2628406
25. Logie L Ruiz-Alcaraz AJ Keane M: Characterization of a protein kinase B inhibitor in vitro and in insulin-treated liver cells. Diabetes. 2007;56(9):2218-27. 17563061 10.2337/db07-0343
26. Bain J Plater L Elliott M: The selectivity of protein kinase inhibitors: a further update. Biochem J. 2007;408(3):297-315. 17850214 10.1042/BJ20070797 2267365
27. Shibagaki N Hanada K Yamaguchi S: Functional analysis of CD82 in the early phase of T cell activation: roles in cell adhesion and signal transduction. Eur J Immunol. 1998;28(4):1125-33. 9565351 10.1002/(SICI)1521-4141(199804)28:04&<1125::AID-IMMU1125&>3.0.CO;2-C
28. Lebel-Binay S Lagaudrière C Fradelizi D: CD82, member of the tetra-span-transmembrane protein family, is a costimulatory protein for T cell activation. J Immunol. 1995;155(1):101-10. 7602090
29. Xia MQ Tone M Packman L: Characterization of the CAMPATH-1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone. Eur J Immunol. 1991;21(7):1677-84. 1711975 10.1002/eji.1830210714
30. Rowan WC Hale G Tite JP: Cross-linking of the CAMPATH-1 antigen (CD52) triggers activation of normal human T lymphocytes. Int Immunol. 1995;7(1):69-77. 7718516 10.1093/intimm/7.1.69
31. Watanabe T Masuyama J Sohma Y: CD52 is a novel costimulatory molecule for induction of CD4+ regulatory T cells. Clin Immunol. 2006;120(3):247-59. 16797237 10.1016/j.clim.2006.05.006
32. Jastrzebski K Hannan KM Tchoubrieva EB: Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function. Growth Factors. 2007;25(4):209-26. 18092230 10.1080/08977190701779101
33. Bin Amer SM Maqbool Z Nirmal MS: Gene expression profiling in women with breast cancer in a Saudi population. Saudi Med J. 2008;29(4):507-13. 18382789
34. Doherty L Sheen MR Vlachos A: Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia. Am J Hum Genet. 2010;86(2):222-8. 20116044 10.1016/j.ajhg.2009.12.015 2820177
35. Ziemiecki A Müller RG Fu XC: Oncogenic activation of the human trk proto-oncogene by recombination with the ribosomal large subunit protein L7a. EMBO J. 1990;9(1):191-6. 2403926 551645
36. Artero-Castro A Castellvi J García A: Expression of the ribosomal proteins Rplp0, Rplp1, and Rplp2 in gynecologic tumors. Hum Pathol. 2011;42(2):194-203. 21040949 10.1016/j.humpath.2010.04.020
37. Tzivion G Dobson M Ramakrishnan G: FoxO transcription factors; Regulation by AKT and 14-3-3 proteins. Biochim Biophys Acta. 2011;1813(11):1938-45. 21708191 10.1016/j.bbamcr.2011.06.002
38. Hedrick SM Hess Michelini R Doedens AL: FOXO transcription factors throughout T cell biology. Nat Rev Immunol. 2012;12(9):649-61. 22918467 10.1038/nri3278
39. van der Vos KE Coffer PJ: The extending network of FOXO transcriptional target genes. Antioxid Redox Signal. 2011;14(4):579-92. 20673124 10.1089/ars.2010.3419
40. Paik JH Kollipara R Chu G: FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell. 2007;128(2):309-23. 17254969 10.1016/j.cell.2006.12.029 1855089
41. Terragni J Graham JR Adams KW: Phosphatidylinositol 3-kinase signaling in proliferating cells maintains an anti-apoptotic transcriptional program mediated by inhibition of FOXO and non-canonical activation of NFkappaB transcription factors. BMC Cell Biol. 2008;9:6. 18226221 10.1186/1471-2121-9-6 2268685
42. Hers I Vincent EE Tavare JM: Akt signalling in health and disease. Cell Signal. 2011;23(10):1515-27. 21620960 10.1016/j.cellsig.2011.05.004
43. Manning BD Cantley LC: AKT/PKB signaling: navigating downstream. Cell. 2007;129(7):1261-74. 17604717 10.1016/j.cell.2007.06.009 2756685
44. Heinonen H Nieminen A Saarela M: Deciphering downstream gene targets of PI3K/mTOR/p70S6K pathway in breast cancer. BMC Genomics. 2008;9:348. 18652687 10.1186/1471-2164-9-348 2496917
45. Latres E Amini AR Amini AA: Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem. 2005;280(4):2737-44. 15550386 10.1074/jbc.M407517200
46. Maciver NJ Jacobs SR Wieman HL: Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukoc Biol. 2008;84(4):949-57. 18577716 10.1189/jlb.0108024 2638731
47. Kane LP Weiss A: The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3. Immunol Rev. 2003;192(1):7-20. 12670391 10.1034/j.1600-065X.2003.00008.x
48. Obar JJ Jellison ER Sheridan BS: Pathogen-induced inflammatory environment controls effector and memory CD8+ T cell differentiation. J Immunol. 2011;187(10):4967-78. 21987662 10.4049/jimmunol.1102335 3208080
49. Kallies A: Distinct regulation of effector and memory T-cell differentiation. Immunol Cell Biol. 2008;86(4):325-32. 18362944 10.1038/icb.2008.16
50. Riou C Yassine-Diab B Van Grevenynghe J: Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells. J Exp Med. 2007;204(1):79-91. 17190839 10.1084/jem.20061681 2118424
51. Kim EH Sullivan JA Plisch EH: Signal integration by Akt regulates CD8 T cell effector and memory differentiation. J Immunol. 2012;188(9):4305-14. 22467649 10.4049/jimmunol.1103568 3331885
52. Chan JC Hannan KM Riddell K: AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer. Sci Signal. 2011;4(188):ra56. 21878679 10.1126/scisignal.2001754
53. Kerdiles YM Stone EL Beisner DR: Foxo transcription factors control regulatory T cell development and function. Immunity. 2010;33(6):890-904. 21167754 10.1016/j.immuni.2010.12.002 3034255
54. Haxhinasto S Mathis D Benoist C: The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J Exp Med. 2008;205(3):565-74. 18283119 10.1084/jem.20071477 2275380
55. Sauer S Bruno L Hertweck A: T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A. 2008;105(22):7797-802. 18509048 10.1073/pnas.0800928105 2409380
56. Nie Z Hu G Wei G: c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell. 2012;151(1):68-79. 23021216 10.1016/j.cell.2012.08.033 3471363
57. Boon K Caron HN van Asperen R: N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J. 2001;20(6):1383-93. 11250904 10.1093/emboj/20.6.1383 145518